Health Care

FDA approves second drug to prevent HIV infection

FDA approves second drug to prevent HIV infection”

However, the FDA followed the advice of its advisor committee and didn't approve use of the drug in people at-risk for HIV from receptive vaginal sex, saying the data in this case wasn't strong enough.

Truvada was also approved as a daily pill for pre-exposure prophylaxis, or PrEP, in 2012.

Rates of new HIV infections in the United States plateaued after years of steady decline, the Centers for Disease Control and Prevention reported in February.

Descovy is a prescription medicine approved by the US FDA for the treatment of HIV infection in adults and children who weigh at least 35 kg when used together with other HIV medicines, according to the National Institutes of Health website. But this approval for prevention does not include the women to prevent HIV infection. From 48 to 96 weeks, researchers examined participants who took Descovy and compared them to those who took Truvada.

In a statement, the FDA said that Descovy's efficacy in preventing HIV transmission was similar to Truvada (emtricitabine/tenofovir disoproxil fumarate), which became the first drug approved in the U.S. for PrEP in 2012, and has since grown into a $3bn product, with PrEP estimated to account for around $2bn of that total.

Descovy, a combination drug, was approved in 2016 to treat people already infected with HIV.

More news: Rod Stewart crashes couple’s Las Vegas wedding and sings to them

The U.S. Food and Drug Administration approved the second drug to help prevent HIV infections on Thursday. Enrollment included more than 5,300 adult cisgender men who have sex with men or transgender women (TGW) who have sex with men.

It's a victory for Cuomo's "Ending the Epidemic" initiative, launched in 2014, which aimed to connect undiagnosed patients with proper care and prevent high-risk New Yorkers from contracting the virus, the governor's office said.

The FDA recommends the drug be used as part of a comprehensive strategy to prevent HIV with daily use being combined with safer sex practices like condoms. The trial showed that Descovy was similar to Truvada in reducing the risk of acquiring HIV-1 infection.

Descovy does not prevent other sexually transmitted infections or cure HIV infection or AIDS.

More than 1 million people in the U.S. live with HIV, and 1 in 7 people living with the virus are undiagnosed. The most common adverse reaction in individuals without HIV who were taking Descovy for PrEP was diarrhea. However, it is not intended for those who have receptive vaginal sex as the effectiveness of this population has not been evaluated.

Gilead Sciences, a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.

Like this



07 October 2019
MDHHS reports first death in state from vaping-related lung injury
MI is the latest state to report a death from a lung injury that could be tied to vaping. This marks the 19th confirmed death nationally tied to vaping-related lung injury.

07 October 2019
Ecuador arrests taxi leader; transport unions end protest
With rising food prices adding to the social pressure, protesters have called for a national strike on Wednesday. The subsidies had been costing the federal government $1.three billion a 12 months.

07 October 2019
Tesla shares fall as it misses delivery estimates
Following this investigation, which affected about 2000 vehicles, Tesla shares fell 0.7% on Friday, closing the day at $ 231.43. Ultimately, we'll know more once the company delivers its third-quarter earnings on October 24.

07 October 2019
Why six million insurance policyholders are not getting a good deal
FCA Executive Director of Strategy & Competition Christopher Woolard added: "This market is not working well for all consumers". The FCA said it launched the study because it was "concerned about the potential harm to consumers from pricing practices".

07 October 2019
Manchester United make history with pathetic attacking display vs. AZ Alkmaar
Manchester United failed to have a shot on target in a UEFA Europa League game for the first time in their history (25 games). Sevilla, the most successful team in the Europa League made it two wins from two after with a 1-0 home win against APOEL.

07 October 2019
BEA: U.S. International Trade in Goods and Services, August 2019
The deficit increased from $54.0 billion in July (revised) to $54.9 billion in August, as imports increased more than exports. Exports of industrial supplies and materials increased $1.5 billion, with shipments of crude oil rising $0.8 billion.

07 October 2019
Cops use stun gun on 'Jersey Shore' star before arresting him
Neither Harley nor the baby suffered major injuries, though Harley did have marks on her face, the outlet reported. When officers [were] on location, the suspect was uncooperative. "There was a little one at the scene, unharmed".

07 October 2019
Call of Duty: Mobile Is A Big Hit
Headquartered in Santa Monica, California, Activision is a leading global producer and publisher of interactive entertainment. TiMi strives to create high quality, high fidelity and highly accessible games across a wide variety of genres.

07 October 2019
Tom Holland Saves Spider-Man, Brings Him Back To The MCU
Spider-Man is a powerful icon and hero whose story crosses all ages and audiences around the globe". If not, here's a quick recap: Sony owns the movie rights to the character of Spider-Man.

07 October 2019
Fed policymakers 'open' to rate cut as risks to outlook rise
President Donald Trump has repeatedly urged the Fed to slash interest rates and said a strong dollar is hurting U.S. factories. The Fed has cut interest rates twice this year to shelter the US economy from weak global growth and trade-policy uncertainty.